$HTGM 1/15/19 H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on HTG Molecular Diagnostics (HTGM – Research Report) today and set a price target of $8. The company’s shares closed yesterday at $2.33, close to its 52-week low of $2.13.
Currently, the analyst consensus on HTG Molecular Diagnostics is a Strong Buy with an average price target of $7.13, which is a 206.0% upside from current levels. In a report issued on January 7, Cantor Fitzgerald also maintained a Buy rating on the stock with a $7 price target.
if this breaks $7/share tomorrow, im gonna go hang myself for not buying when i found it at $3.15/share
f
I'm trying to load more shares at $3.50
L
Should I buy this stock today any predictions on what this will do today I need some help I have been on a terrible streak lately! Need some good advice
so lets take a wild guess. htgm closes red again. I will guess 3.40 to 3.43. I'm hoping it forms a bottom no lower than 2.75 to 3
A
$HTGM conversation
Any one know why it is jumping in after hours?
R
I bought in at $10.05 sold at $10.90, then stupidly bought back in at $12.13. Feel very very fortunate to have gotten out again at $12.13. I'm done for the day, have a great weekend
F
Today they filed an 8k . They changed the bonus structure of top exec. Everyone that is complaining about this stock don't even know why it's moving up or down....
buy now. been saying for a while that this thing won't go below 5.50
C
$HTGM conversation
I didn't do my research yet, but if this company needs $$, a secondary is very likely at any given moment afterhours. Watch out. I lost 15 grand with Aurinia 2 weeks ago. Just be careful how much you invest in this one!
J
$HTGM conversation
Here we go! She's heating back up guys and gals! I have my heavy position, do you?
T
Really worry next Monday now,,,,I hope this stock will be up ......bought 10,62,,,,
$HTGM 1/15/19 H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on HTG Molecular Diagnostics (HTGM – Research Report) today and set a price target of $8. The company’s shares closed yesterday at $2.33, close to its 52-week low of $2.13.
Currently, the analyst consensus on HTG Molecular Diagnostics is a Strong Buy with an average price target of $7.13, which is a 206.0% upside from current levels. In a report issued on January 7, Cantor Fitzgerald also maintained a Buy rating on the stock with a $7 price target.
$HMNY $HTGM $TIK